BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7.6600
14-十一月-24 10:42:13
15 分钟延时
股票
+0.0200
+0.26%
今日范围
7.5500 - 7.7400
ISIN
N/A
来源
NASDAQ
-
27 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2022 Financial Results on May 5
21 4月 2022 07:00:52 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
11 4月 2022 08:30:49 条件 Nasdaq GlobeNewswire
-
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
08 4月 2022 09:15:13 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4月 2022 07:15:42 条件 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
03 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
23 2月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2021 Financial Results on February 23
09 2月 2022 07:00:00 条件 Nasdaq GlobeNewswire